The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is the third leading cause of cancer-related deaths, characterised by poor survival, marked molecular heterogeneity and high intrinsic and acquired chemoresistance. Only 10–20% of pancreatic cancer patients present with surgically resectable disease and even then, 80% die within 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkin, Ashleigh, Man, Jennifer, Chou, Angela, Nagrial, Adnan M, Samra, Jaswinder, Gill, Anthony J, Timpson, Paul, Pajic, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313363/
https://www.ncbi.nlm.nih.gov/pubmed/30428574
http://dx.doi.org/10.3390/diseases6040103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313363/
https://www.ncbi.nlm.nih.gov/pubmed/30428574
http://dx.doi.org/10.3390/diseases6040103

Ejemplares similares